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Vasculitic neuropathies are a heterogeneous and rare group of peripheral nerve disorders. They are categorized into two groups: primary nonsystemic vasculitic neuropathies (NSVNs) affect only the peripheral nervous system, whereas secondary vasculitic neuropathies evolve in the context of a primary systemic vasculitis. NSVNs affect the minority of cases, accounting for 15% \[[@B1]\]. Classification criteria are not standardized, but recently, comprehensive diagnostic criteria have been proposed \[[@B2]\]: (1) clinical evidence of neuropathy; (2) electrodiagnostic changes consistent with axonal neuropathy; (3) nerve or nerve/muscle biopsy diagnostic of vasculitis; (4) without clinical, laboratory, or radiological evidence of nonneuromuscular involvement; (5) no identified other disease etiology, and (6) no systemic disease predisposing to vasculitis. As with systemic vasculitic neuropathy (SVN), NSVN most commonly presents as mononeuritis multiplex. Nevertheless, it can also occur as symmetrical polyneuropathy \[[@B3]\] and asymmetrical sensory or motor neuropathy \[[@B4]\]. Thus, NSVN should be suspected particularly if an axonal neuropathy is asymmetric, multifocal, progressive, and painful and is associated with a paresis. The peroneal, tibial, and ulnar nerves are mostly affected. Almost all vasculitic neuropathies develop acutely or subacutely; a chronic development over years is quite rare. Unspecific symptoms, such as weight loss, fever, or fatigue, have been reported in 80% of cases in systemic vasculitis and to a lower percentage also in NSVNs \[[@B4]\].

NSVN is a challenging diagnosis. An extensive workup \[i.e. clinical examination, nerve conduction studies (NCS), electromyography, and laboratory tests including urine analysis\] is necessary mainly to exclude different etiologies. A definitive diagnosis can only be achieved by a nerve biopsy. However, it is limited by a low sensitivity. Sural nerve biopsy was diagnostic in 37-58% of patients with SVNs \[[@B5],[@B6]\] but only in 25% of those with NSVNs \[[@B5]\]. Moreover, sensorimotor and pure motor nerves cannot be biopsied without the risk of additional neurological disabilities. Therefore, alternative and noninvasive methods to determine the diagnosis are much appreciated. The value of ultrasound of the peripheral nerves in acquired immune-mediated neuropathies has been reported in detail \[[@B7]\]. The impact of neurosonography in vasculitic neuropathy has just recently been described. Grimm et al. \[[@B8]\] could demonstrate morphological changes in vasculitic neuropathy with focal nerve enlargement but no pronounced general nerve enlargement as expected in immune-mediated demyelinating neuropathies (e.g. chronic inflammatory demyelinating neuropathy). Our case report highlights neurosonography changes in a patient with NSVN at first diagnosis and in response to immunosuppression.
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Neurosonography was performed using a Philips EPIQ 5 imaging system with an 18-MHz linear-array transducer. All peripheral nerves were measured bilaterally (median, ulnar, radial, brachial plexus, tibial, fibular, and sural nerves). Each nerve was scanned according to standard protocols, and the maximal cross-sectional area (CSA) was measured at the inner border of the hyperechoic epineural rim. Published normal values adapted to local standards were used for comparison \[[@B9]\].

NCS were performed bilaterally with modern electrodiagnostic equipment (Dantec™ Keypoint®) on the same day as the sonographic evaluation. Normal values were derived from institutional standards. Motor nerve conduction velocities (NCVs) of the median, ulnar, radial, peroneal, and tibial nerves were investigated. Sensory NCVs were determined for the median, ulnar, radial, peroneal, and sural nerves.

Case Description {#sec1_3}
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A 44-year-old female presented with right-sided severe neuropathic pain at the scapula radiating along the dermatomes C8/Th1 as well as burning pain at the fingertips, which gradually developed over 1 month. Additionally, the patient complained of weakness of the right hand. Two weeks before admission, she had noticed painful dysesthesias in the left fingers and the right knee (cutaneous branches of the femoral nerve).

The clinical examination revealed severe paresis of the right intrinsic hand muscles (Medical Research Council grade 3 paresis) and sensory deficits in the territory of both the median and right axillary nerves. There was a pronounced allodynia along the course of the upper arm nerves. Fever, night sweats, and weight loss were not reported. The serum and urine laboratory tests and cerebrospinal fluid analysis were unremarkable without evidence of an infectious, inflammatory, or systemic vasculitic disease. The magnetic resonance images of the brain, the cervical spine, and plexus brachialis with and without gadolinium were also normal. NCS revealed a severe axonal neuropathy of the right median and ulnar nerve with reduced compound muscle action potential amplitudes and sensory nerve action potentials, while NCVs were in the normal range. Electromyography of the paretic muscles (e.g. first dorsal interosseous and abductor pollicis brevis) showed a neurogenic pattern including spontaneous muscle fiber activity and polyphasic, extended, and high-amplitude motor unit action potentials, whereas clinically unaffected muscles innervated by different nerves were normal. On nerve ultrasound, multifocal swelling of the right median and ulnar nerves with enlarged CSAs was detected. Interestingly, we frequently found isolated enlarged nerve fascicles in the affected nerves. Beside enlargement, the affected nerves showed a decreased echogenicity with a hyperechogenic, thickened epineurium (fig. [1](#F1){ref-type="fig"}, fig.[2](#F2){ref-type="fig"}). Focally increased CSA was also detected in the electrophysiologically unaffected left median und ulnar nerves. On the side of nerve enlargement, compression with the ultrasound probe was painful.

In summary, subacute and asymmetric painful neuropathy in different nerve regions, axonal changes at electrodiagnostic examination, and missing clinical, laboratory, and radiological evidence of nonneuromuscular involvement and systemic vasculitic diseases as well as no other identified etiology strongly point to the diagnosis of NSCN \[[@B2]\]. However, a definitive diagnosis could not be achieved, as nerve biopsy was not feasible due to the affected sensorimotor nerves (i.e. median and ulnar nerves). Other terminal sensory nerves suitable for nerve biopsy (i.e. sural or radial nerves) were neither clinically, electrophysiologically nor sonographically affected.

As initial intravenous high-dose steroids were insufficient to alleviate the clinical symptoms, immunosuppression was escalated to a combined treatment with 6 monthly courses of intravenous cyclophosphamide (500 mg/m^2^ body surface). After 2 months of treatment, neuropathic pain greatly improved, and neurological deficits stabilized. Finally, after tapering of immunosuppression, muscle strength returned to normal. However, NCS remained unchanged, showing persistent and severe axonal damage of the right median and ulnar nerves. In contrast, neurosonography findings improved remarkably. The pathological enlargement of single nerve fascicles diminished, and the overall swelling of the affected nerves was reduced; nerve echogenicity remained decreased in the affected nerves (fig. [3](#F3){ref-type="fig"}). For long-term immunosuppression, therapy was switched to azathioprine monotherapy (3 mg/kg body weight daily).

Discussion {#sec1_4}
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Superficial peripheral nerves can thoroughly be investigated by high-resolution neurosonography. Hence, neurosonography might advance to become a useful complementary tool to electrodiagnostic studies, as it allows the detailed visualization of nerve fascicles and small structural changes \[[@B10]\]. The value of peripheral nerve ultrasound has already been established in acquired immune-mediated demyelinating neuropathies like acute and chronic inflammatory demyelinating neuropathy as well as in inherited demyelinating neuropathies \[[@B7],[@B11]\]. Increased CSAs of the affected nerves, especially in the proximal extremities, and patchy nerve enlargement at the site of conduction blocks are the hallmarks of sonographic findings in demyelinating neuropathies. The distribution pattern of nerve alterations (diffuse, generalized, or focal) can give etiological clues of demyelinating neuropathies \[[@B12]\]. In contrast, ultrasound is rarely abnormal in diffuse axonal polyneuropathies. Hence, neurosonography seems to be useful for the morphological delineation between axonal and demyelination neuropathies \[[@B13]\].

In contrast, vasculitic neuropathy may be an exception in the context of these findings. In our case, we illustrated pronounced changes of different nerves using ultrasound. Besides multifocal nerve swelling, we found impressively enlarged nerve fascicles in the affected nerves. The affected nerves showed a decreased echogenicity with a hyperechogenic, thickened epineurium, which persisted even after immunosuppression. Just a few case reports of vasculitic neuropathies are available where focal morphologic lesions were sonographically identified. Ito et al. \[[@B14]\] described abnormalities in tibial nerve vasculitic neuropathy with an enlarged and hypoechoic nerve. Recently, Grimm et al. \[[@B8]\]reported on systematic peripheral nerve measurements in vasculitic neuropathies using ultrasound. In patients with primary or secondary SVN, single fascicle enlargements in clinically affected nerves were detected. Given that nonimmune-mediated axonal neuropathies in general do not show significant nerve enlargement, nerve ultrasound might be a helpful additional tool to NCS in case of asymmetric axonal damage of unknown origin. In comparison with demyelinating neuropathies with generalized nerve enlargements, accentuated in proximal nerve segments, in vasculitic neuropathy mean CSA values are just slightly increased, whereas focal nerve enlargement and particularly fascical swelling are more prominent in these cases. The findings in our case are in agreement with the study by Grimm et al. \[[@B8]\]. The pathophysiology of nerve enlargement and fascicular swelling in vasculitic neuropathies remains unclear. It might be an inflammation of the vasa nervorum, mainly affecting the epineural arteries, leading to small-vessel infarction and thrombosis, focal edema, and consecutive ischemic damage of the axon \[[@B15]\]. The different etiology and rapid time course might explain the peculiar presentation of NSVN compared to other axonal neuropathies.

The main limitation of the differential diagnosis in our case was the missing histological verification of NSVN due to the affected eloquent nerves of the upper extremity. We considered the risk of neurological harm due to a nerve biopsy carefully in view of the low sensitivity of this procedure \[[@B6]\] and decided in favor of a conservative approach. However, asymmetric and painful axonal mononeuropathy multiplex without evidence of an alternative etiology or the presence of clinical and paraclinical parameters of systemic vasculitis raises suspicion of NSVN, as 5 out of the 6 proposed diagnostic criteria were already present \[[@B2]\]. Moreover, by nerve ultrasound we identified morphological findings consistent with the diagnosis of NSVN and documented a sonographic response along with the alleviation of clinical symptoms achieved by intensive systemic immunosuppression. Just recently, different study groups described nerve ultrasound changes in immune-mediated neuropathies after immunoglobulin therapy over time. In chronic inflammatory demyelinating neuropathy patients, a correlation between muscle strength and CSA variability could be illustrated \[[@B16]\]; also, in Guillain-Barré syndrome patients, a regression of nerve enlargement might be a good parameter for clinical restitution during follow-up \[[@B17]\]. Therefore, nerve ultrasound might be a promising monitoring method, although literature on proven therapeutic effects of ultrasound in vasculitic neuropathy is missing and sample sizes in immune-mediated neuropathies are small. Further studies need to prove these effects. In summary, nerve ultrasound is a new and noninvasive diagnostic tool for the confirmation of peripheral nerve vasculitis supplementary to electrophysiological studies. It is easy to use in experienced hands, cheap, and probably a better follow-up instrument than NCS or electromyography, as it showed earlier response and a better correlation with the clinical follow-up in our case. Furthermore, nerve enlargement can be detected in clinically and electrophysiologically unaffected nerves.
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![Axial ultrasound of the right median nerve. **a**, **b** Multifocal nerve enlargements at different nerve sites with increased CSA (arrows) and significant interfascicular swelling (\>2 mm^2^) (asterisks). **c** Enlarged median nerve (arrows) compared to healthy nerve segment (**d**) (arrows) on the left side (CSA 12 vs. 8 mm^2^).](crn-0008-0108-g01){#F1}

![Multifocal swelling of the right ulnar nerve (**a**) with hyperechogenic epineurium (arrow) and interfascicular swelling (asterisks) compared to the healthy ulnar nerve segment on the left in the upper arm (**b**) (CSA 10 vs. 5 mm^2^).](crn-0008-0108-g02){#F2}

![Axial ultrasound of the median nerve 6 months after treatment with cyclophosphamide. **a**, **b** Normal CSA in different nerve segments with persistent mild swelling of single fascicles (\<1 mm in diameter). **c** Normal values of CSA in the upper arm with persistent hypoechogenic nerve structure without discrimination of different fascicles.](crn-0008-0108-g03){#F3}
